Marksans Pharma Limited at its meeting held 31 May, 2021 recommended dividend of INR 0.25 (Rupees Zero and Paise Twenty Five) i.e. 25% per equity share of INR 1 each face value for the financial year ended March 31, 2021, subject To Approve the shareholders in the ensuing Annual General Meeting.